Litigation Details for Duke University v. Alcon Laboratories, Inc. (D. Del. 2018)
✉ Email this page to a colleague
Duke University v. Alcon Laboratories, Inc. (D. Del. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-05-01 |
Court | District Court, D. Delaware | Date Terminated | 2018-10-05 |
Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
Jury Demand | None | Referred To | |
Patents | 7,388,029; 9,579,270 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Duke University v. Alcon Laboratories, Inc.
Details for Duke University v. Alcon Laboratories, Inc. (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-10-04 | 12 | Stipulation of Dismissal | concerning patent validity or claim construction of claims 22 and 30 of U.S. Patent No. 9,579,270 rendered…concerning patent validity or claim construction of claims 22 and 30 of U.S. Patent No. 9,579,270 rendered… claims 22 and 30 of U.S. Patent No. 9,579,270, which are the only patent claims asserted in the Delaware…the validity of claims 22 and 30 of U.S. Patent No. 9,579,270 are upheld in the Sandoz Action (including…infringement of claims 22 and 30 of U.S. Patent No. 9,579,270. 5. Alcon agrees that, to the | External link to document |
2018-04-03 | 2 | Complaint | litigated other patents that cover LATISSE®, including U.S. Patent No. 7,388,029 (“the ’029 Patent”), to which…infringement of United States Patent No. 9,579,270 (“the ’270 Patent”) under the Patent Laws of the United States…exclusive license to the ’270 Patent. 36. The ’270 Patent has a patent term that expires on January…February 28, 2017, United States Patent No. 9,579,270 (“the ’270 Patent”), titled “Compositions and Methods… the ’270 Patent is attached to this complaint as Exhibit B. 34. The ’270 Patent is assigned | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |